Spring Bank Pharmaceuticals, Inc. Business Finance Contracts & Agreements

Side Letter, dated June 30, 2021, to (a) the License and Collaboration Agreement, dated August 24, 2016, by and among BBB Holding Ltd (f/k/a F-star Gamma Limited, DBH ), F-star... (Filed With SEC on August 13, 2021)

Form of Warrant issued under the Venture Loan and Security Agreement, dated April 1, 2021 (Filed With SEC on May 17, 2021)

Venture Loan and Security Agreement, dated April 1, 2021, by and among F-star Therapeutics, Inc., as borrower, F-star Therapeutics Limited, as guarantor, and Horizon Technology... (Filed With SEC on May 17, 2021)

Underwriting Agreement, dated May 6, 2021, between F-star Therapeutics, Inc. and SVB Leerink LLC (Filed With SEC on May 10, 2021)

STING Antagonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare... (Filed With SEC on November 20, 2020)

STING Agonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare Inc.,... (Filed With SEC on November 20, 2020)

Form of Restricted Stock Unit Agreement (Filed With SEC on May 7, 2020)

Form of Amended and Restated Warrant (Filed With SEC on April 13, 2020)

Loan and Security Agreement, dated September 3, 2019 (Filed With SEC on September 4, 2019)

Underwriting Agreement, dated August 8, 2018, by and among the Company, Jefferies LLC and Piper Jaffray & Co (Filed With SEC on August 9, 2018)

Spring Bank Pharmaceuticals, Inc. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on August 18, 2017)

2,884,615 Shares Spring Bank Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 23, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 21, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 21, 2016)

Spring Bank Pharmaceuticals, Inc. Common Stock Purchase Warrant (Void after [ ], 2021) (Filed With SEC on May 13, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 27, 2016)

Spring Bank Pharmaceuticals, Inc. Common Stock Purchase Warrant (Void after , 2021) (Filed With SEC on April 27, 2016)

[] Shares Spring Bank Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 27, 2016)

[ ] Shares Spring Bank Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 9, 2016)

THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE LEGENDS AND THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THISWARRANT (Filed With SEC on March 9, 2016)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDED AND RESTATED LICENSE AGREEMENT BY AND... (Filed With SEC on January 15, 2016)

SPRING BANK TECHNOLOGIES, INC. AND MICROLOGIXBIOTECH, INC. STOCK PURCHASE AGREEMENT DECEMBER 17, 2003 STOCK PURCHASE AGREEMENT (Filed With SEC on January 5, 2016)

SPRING BANK PHARMACEUTICALS, INC. NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on January 5, 2016)